Stuart Diamond Bio Affinity Technologies, Inc. (BIAF) insider trading activity

Stuart Diamond is Director of bioAffinity Technologies, Inc.. Currently has a direct ownership of 99,088 shares of BIAF, which is worth approximately $121,878. The most recent transaction as insider was on Jul 01, 2024, when has been sold 33,784 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.1K

0% 3M change

123.47% 12M change

Total Value Held $121,878

STUART DIAMOND Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 01 2024	BUY Grant, award, or other acquisition	-	33,784 Added 25.43%	99,088 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	8,296 Added 11.27%	65,304 Common Stock
Jan 01 2024	BUY Grant, award, or other acquisition	$18,748 $1.48 p/Share	12,668 Added 18.18%	57,008 Common Stock
Oct 01 2023	BUY Grant, award, or other acquisition	$18,749 $1.58 p/Share	11,867 Added 21.11%	44,340 Common Stock
Jul 01 2023	BUY Grant, award, or other acquisition	$18,748 $1.83 p/Share	10,245 Added 23.98%	32,473 Common Stock
Apr 15 2023	BUY Grant, award, or other acquisition	$18,748 $1.89 p/Share	9,920 Added 30.86%	22,228 Common Stock
Jan 01 2023	BUY Grant, award, or other acquisition	$18,757 $2.28 p/Share	8,227 Added 40.06%	12,308 Common Stock
Aug 31 2022	BUY Open market or private purchase	-	4,081 Added 50.0%	4,081 Common Stock, par valu...

Stuart Diamond

Director

Great Neck, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIAF shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Affinity Technologies, Inc. insider buys or sells BIAF shares.

Notify only if

Operation

Value

Type

News

Receive news related to bioAffinity Technologies, Inc.

Track Activities on BIAF

Account